Clinical Trial

Extension Study of NS-089/NCNP-02 in DMD

Name: Extension Study of NS-089/NCNP-02 in DMD — clinical trial record (NCT05135663)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is the extension study of NS-089/NCNP-02 (Study NCNP/DMT02), which is designed to assess the safety, tolerability and efficacy of NS-089/NCNP-02 in patients with Duchenne muscular dystrophy (DMD).

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2021-11-16; most recent amendment 2025-07-16.

Trial Details

NCT Number	NCT05135663
Lead Sponsor	Nippon Shinyaku Co., Ltd.
Conditions	Duchenne Muscular Dystrophy (DMD)
Enrollment	6 participants
Start Date	2021-06-23
Primary Completion	2027-04-30 (estimated)
Study Completion	2027-04-30 (estimated)
Updated on ClinicalTrials.gov	2025-07-20